3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Rectal Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Neoplasm, Residual
2
Mesothelioma, Malignant
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sarcopenia
1
Sarcoglycanopathies
1
Peritoneal Neoplasms
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Pancreatic Neoplasms
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Mesothelioma
1
Melanoma
1
Malnutrition
1
Lung Neoplasms
1
HER2 Negative Breast Cancer
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Frailty
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Interventions
Radiosurgery
50
Magnetic Resonance Spectroscopy
34
Temozolomide
28
Bevacizumab
24
pembrolizumab
23
Radiotherapy
20
Nivolumab
20
Specimen Handling
14
Ipilimumab
13
Cyclophosphamide
13
Mental Status and Dementia Tests
12
Carboplatin
12
abemaciclib
10
Radiation
10
trastuzumab deruxtecan
8
Proton Therapy
7
Pemetrexed
7
Memantine
7
Blood Specimen Collection
7
fluciclovine F-18
6
binimetinib
6
Paclitaxel
6
Lomustine
6
Etoposide
6
Cisplatin
6
Capecitabine
6
encorafenib
5
Trastuzumab
5
Surveys and Questionnaires
5
Surgical Procedures, Operative
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Chemotherapy, Adjuvant
×
1 year
×
Clear all
No trials found.